Surge in pharma funding observed in August 2024, reached $135 mn EP News Bureau Sep 6, 2024 As per Traxcn.com, an increase of 382 per cent was observed as funding rocketed from $28 mn in July
Pharmazz, Dr Reddy’s enter licensing pact to market Centhaquine in India EP News Bureau Mar 22, 2024 Centhaquine is a resuscitative agent to treat hypovolemic shock by increasing stroke volume and cardiac output due to an increase…
Sun Pharma and Pharmazz sign licensing pact to launch Tyvalzi (Sovateltide) in India EP News Bureau Sep 14, 2023 Sovateltide is indicated for treating cerebral ischemic stroke
Centhaquine set to enter US-FDA approved Phase 3 clinical trial in US and Europe EP News Bureau Aug 2, 2023 Pharmazz India obtained marketing authorization for the management of Hypovolemic shock Lyfaquin (INN: Centhaquine) in India in…